Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.9800 (7.87%) ($8.3400 - $9.0900) on Thu. Dec. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 40 | Latest Price | $8.9800(7.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(57%) IWC(52%) IWM(48%) IWO(48%) IWN(46%) | Factors Impacting EDIT price | EDIT will decline at least -2.29% in a week (0% probabilities). SMH(-6%) ARKK(-6%) ARKG(-6%) GLD(-2%) BOTZ(0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | 0 () | Intraday Trend | 6.3% | | | |
|
1 - 5 Day Possible Target | $-2.97(-133.07%) | Resistance Level | $9.49 | 5 Day Moving Average | $8.72(2.98%) | 10 Day Moving Average | $9.11(-1.43%) | 20 Day Moving Average | $9.49(-5.37%) | To recent high | -32.1% | To recent low | 7.9% | Market Cap | $558m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |